Diasorin | DIA - Gross Profit On Sales

Stock Price
73.48
Daily Change
-1.10 -1.47%
Monthly
2.37%
Yearly
-26.78%
Q1 Forecast
70.01

Diasorin reported EUR181.08M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Amplifon EUR 103.17M 44.14M Sep/2025
Avanos Medical USD 86M 6.1M Sep/2025
Brookdale Senior Living USD 210.85M 7.15M Sep/2025
Cencora USD 2.96B 48.98M Sep/2025
Diasorin EUR 181.08M 19.92M Sep/2025
Encompass Health USD 1.41B 786M Sep/2025
Enovis USD 328.91M 12.59M Sep/2025
GE HealthCare Technologies USD 1.99B 4M Sep/2025
OPKO Health USD 46.89M 27.83M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025